← Leaderboards
Carina Mari Aparici
Oregon Health & Science University
$403,606
Attributed
$999,096
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $451.5K · FY2020–25$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$999,096 · 1
By mechanism
R01$999,096 · 1
Top collaborators
- Shivaani Kummar4 shared
- Erik S. Mittra3 shared
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Dennis Roop$22,231,168
- Peter Nicholas Robinson$10,536,686
- Jacob D Estes$17,454,041
- Wei Huang$3,136,798
- Shivaani Kummar$2,160,891
Others in their field
Other Emerging Leaders on “Dose”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$124,321,134
- Beth Baseler · Leidos Biomedical Research, Inc.$52,807,683
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Paula Gonzalez-Maya · Fundacion Inciensa$37,578,679
- Xinhua Li · Nano Terra, Inc.$35,520,438
- Jeffrey Reich · Sparian Biosciences, Inc.$28,575,028
Research focus
DoseAdvanced Malignant NeoplasmAdverse EventAntibodiesAreaAftercareAnalogBiological MarkersBiopsyBloodCancer TherapyCd4 Positive T LymphocytesCd8b1 GeneCell Mediated Immune ResponseCell PhysiologyCellsCheckpoint TherapyClinical TrialsColitisComplexConfidence IntervalsData ReportingDiarrheaDrug Design
Grant awards (4)
[18F]-AraG -PET imaging to evaluate immunological response to checkpoint inhibitor therapy (CKI) in patients with advanced solid tumors$124,109
R01 · FY2025 · CA
[18F]-AraG -PET imaging to evaluate immunological response to checkpoint inhibitor therapy (CKI) in patients with advanced solid tumors$1
R01 · FY2024 · CA
[18F]-AraG -PET imaging to evaluate immunological response to checkpoint inhibitor therapy (CKI) in patients with advanced solid tumors$451,542
R01 · FY2021 · CA
[18F]-AraG -PET imaging to evaluate immunological response to checkpoint inhibitor therapy (CKI) in patients with advanced solid tumors$423,444
R01 · FY2020 · CA